Two Sigma Advisers’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,195
| Closed | -$22K | – | 2467 |
|
|
2024
Q1 | $22K | Sell |
1,195
-825
| -41% | -$15.2K | ﹤0.01% | 2397 |
|
|
2023
Q4 | $32.1K | Sell |
2,020
-740
| -27% | -$11.8K | ﹤0.01% | 2427 |
|
|
2023
Q3 | $52K | Sell |
2,760
-1,070
| -28% | -$20.2K | ﹤0.01% | 2273 |
|
|
2023
Q2 | $86.6K | Buy |
3,830
+650
| +20% | +$14.7K | ﹤0.01% | 2229 |
|
|
2023
Q1 | $80.8K | Buy |
3,180
+1,890
| +147% | +$48K | ﹤0.01% | 2406 |
|
|
2022
Q4 | $19.5K | Sell |
1,290
-120
| -9% | -$1.82K | ﹤0.01% | 2431 |
|
|
2022
Q3 | $18K | Sell |
1,410
-525
| -27% | -$6.7K | ﹤0.01% | 2446 |
|
|
2022
Q2 | $19K | Sell |
1,935
-5,785
| -75% | -$56.8K | ﹤0.01% | 2552 |
|
|
2022
Q1 | $129K | Sell |
7,720
-19,595
| -72% | -$327K | ﹤0.01% | 2463 |
|
|
2021
Q4 | $694K | Buy |
27,315
+3,885
| +17% | +$98.7K | ﹤0.01% | 1748 |
|
|
2021
Q3 | $1.05M | Buy |
23,430
+21,400
| +1,054% | +$959K | ﹤0.01% | 1598 |
|
|
2021
Q2 | $82K | Sell |
2,030
-2,410
| -54% | -$97.4K | ﹤0.01% | 2358 |
|
|
2021
Q1 | $236K | Buy |
4,440
+2,707
| +156% | +$144K | ﹤0.01% | 2304 |
|
|
2020
Q4 | $69K | Sell |
1,733
-837
| -33% | -$33.3K | ﹤0.01% | 2297 |
|
|
2020
Q3 | $146K | Sell |
2,570
-1,813
| -41% | -$103K | ﹤0.01% | 2221 |
|
|
2020
Q2 | $323K | Buy |
4,383
+2,540
| +138% | +$187K | ﹤0.01% | 2095 |
|
|
2020
Q1 | $91K | Buy |
1,843
+1,143
| +163% | +$56.4K | ﹤0.01% | 2309 |
|
|
2019
Q4 | $54K | Buy |
+700
| New | +$54K | ﹤0.01% | 2290 |
|